PMVP
PMV Pharmaceuticals, IncstockNASDAQ
pmv pharmaceuticals, inc., a precision oncology company, discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. its lead product candidate is pc14586, a small molecule that corrects and restores p53 function. the company also develops product candidates for p53 r273h hotspot mutation and other p53 hotspot mutations. pmv pharmaceuticals, inc. was formerly known as pj pharmaceuticals, inc. and changed to in july 2013. the company was founded in 2013 and is headquartered in cranbury, new jersey.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.21 | 2026-11-12 | +1.65% | 5.211 |
| 1M | 1.26 | 2026-10-19 | -1.99% | 0.907 |
| 3M | 1.28 | 2026-08-19 | -3.91% | 0.615 |
| 6M | 1.31 | 2026-05-19 | -6.11% | 0.648 |
| 1Y | 1.36 | 2025-11-19 | -9.56% | 0.698 |
| 2Y | 1.59 | 2024-11-19 | -22.64% | — |
| 5Y | 25.12 | 2021-11-19 | -95.10% | 1.125 |
PMV Pharmaceuticals, Inc (NASDAQ:PMVP) stock price today is $1.23, and today's volume is 430,867. PMVP is up 0.820% today. The 30 day average volume is 428,860. PMVP market cap is $92.91M with 75.53M shares outstanding.